Improving care for patients with Graves' disease
The Impact of Person Centred Care (PCC) on Mental Outcome and Work Ability in Graves' Disease - the GRAves CarE (GRACE) PCC Project
NA · Vastra Gotaland Region · NCT06309316
This study is testing if a new approach to care that involves patients more actively can help adults with Graves' disease feel less mentally tired and improve their overall health.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 220 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Vastra Gotaland Region (other gov) |
| Locations | 1 site (Gothenburg) |
| Trial ID | NCT06309316 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of person-centred care (PCC) on patients suffering from mental fatigue after experiencing Graves' disease, a common form of hyperthyroidism. It aims to engage patients as active partners in their care, promoting positive coping strategies and enhancing self-efficacy. The hypothesis is that PCC will lead to improvements in mental fatigue, reduced sick leave, and lower recurrence rates of Graves' disease. The study will involve patients aged 18-65 who are experiencing their first episode of Graves' disease.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18-65 who have been diagnosed with their first episode of Graves' disease.
Not a fit: Patients with moderate to severe Graves' eye disease or those unable to comply with the study protocol may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of life for patients by reducing mental fatigue and enhancing their overall well-being.
How similar studies have performed: While the concept of person-centred care is gaining traction, this specific application in Graves' disease is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18-65 years * First time Graves' diseases with elevated FT4 and/or FT3 and positive TSH receptor antibody (TRAb) Exclusion Criteria: * Patients that cannot attend to the protocol * Patients with moderate-severe/ severe Graves' eye disease
Where this trial is running
Gothenburg
- Agneta Lindo — Gothenburg, Sweden (RECRUITING)
Study contacts
- Principal investigator: Helena Filipsson Nyström — Sahlgrenska Universitet sjukhus
- Study coordinator: Agneta Lindo
- Email: agneta.lindo@vgregion.se
- Phone: +46766185481
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Graves Disease, Person Centred Care, Mental fatigue, cost-effectiveness, self-efficacy, eHealth